Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
NCT07629206
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
Low-Risk, Early Stage Breast Cancer
Interventions
DEVICE:
Cryoablation
Sponsor
IceCure Medical Ltd.